NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial

RecruitingNA

Sponsor: University of California, San Francisco

Conditions: Behavioral Intervention, Viral Suppression of HIV Infection, ART Adherence

Interventions: reSTART Objective Adherence Self-Monitoring and Postive Affect mHealth Intervention, urine tenofovir point-of-care self-test

Countries: United States

Men who are living with HIV and use stimulants face many challenges and barriers that may interfere with remembering to take their HIV medication. Forgetting to take HIV medication puts men living with HIV at a greater risk of becoming virally unsuppressed. Researchers are doing this study to test if a remote intervention can help participants improve remembering to take their HIV medications and reduce the HIV viral load among men living with HIV who use stimulants.

Eligibility overview

Sex: MALE

Age: 18 Years to 70 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Prescribed antiretroviral therapy (ART) with a tenofovir-based regimen.
* Documented virologic non-suppression, urine tenofovir testing without tenofovir detected, or self-reported adherence \<100%.
* Reports stimulant use.
* Has a mailing address within the U.S.
* Currently has a smartphone with photo capabilities.

Exclusion Criteria:

* Have any health condition that may interfere with participation or the ability to provide informed consent, including any debilitating or life-threatening conditions.
* Not prescribed ART.
* Unwilling to perform urine self-testing or to attend a local Quest site for viral load monitoring.
* Unable to provide a hair sample of \~50-100 strands of hair that are non-gray, not bleached, and at least 1cm in length

Locations (1)

San Francisco, California, United States